Seres Therapeutics, Inc. - COMMON STOCK (MCRB)

CUSIP: 81750R102

Q3 2023 13F Holders as of 30 Sep 2023

Type / Class
Equity / COMMON STOCK
Shares outstanding
170,403,883
Total 13F shares
107,395,553
Share change
-5,026,838
Total reported value
$255,568,518
Put/Call ratio
72%
Price per share
$2.38
Number of holders
134
Value change
-$20,522,942
Number of buys
73
Number of sells
54

Quarterly Holders Quick Answers

What is CUSIP 81750R102?
CUSIP 81750R102 identifies MCRB - Seres Therapeutics, Inc. - COMMON STOCK in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Seres Therapeutics, Inc. - COMMON STOCK (MCRB) as of Q3 2023

As of 30 Sep 2023, Seres Therapeutics, Inc. - COMMON STOCK (MCRB) was held by 134 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 107,395,553 shares. The largest 10 holders included Flagship Pioneering Inc., FMR LLC, STATE STREET CORP, FEDERATED HERMES, INC., BlackRock Inc., VANGUARD GROUP INC, JANUS HENDERSON GROUP PLC, Point72 Asset Management, L.P., Avoro Capital Advisors LLC, and Eversept Partners, LP. This page lists 134 institutional shareholders reporting positions in this security for the Q3 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.